A detailed history of Financial Enhancement Group LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Financial Enhancement Group LLC holds 1,565 shares of JNJ stock, worth $250,853. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,565
Previous 1,559 0.38%
Holding current value
$250,853
Previous $246,000 7.32%
% of portfolio
0.04%
Previous 0.05%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$144.38 - $157.78 $866 - $946
6 Added 0.38%
1,565 $228,000
Q1 2024

Apr 15, 2024

BUY
$155.22 - $162.74 $5,898 - $6,184
38 Added 2.5%
1,559 $246,000
Q4 2023

Jan 18, 2024

SELL
$145.6 - $158.88 $98,716 - $107,720
-678 Reduced 30.83%
1,521 $238,000
Q3 2023

Oct 17, 2023

BUY
$155.75 - $174.48 $23,362 - $26,172
150 Added 7.32%
2,199 $342,000
Q2 2023

Aug 10, 2023

BUY
$154.35 - $166.11 $52,787 - $56,809
342 Added 20.04%
2,049 $339,000
Q1 2023

May 17, 2023

BUY
$151.05 - $180.26 $7,854 - $9,373
52 Added 3.14%
1,707 $264,000
Q4 2022

Feb 09, 2023

SELL
$160.2 - $179.79 $8,009 - $8,989
-50 Reduced 2.93%
1,655 $292,000
Q1 2022

May 18, 2022

BUY
$158.14 - $179.59 $8,065 - $9,159
51 Added 3.08%
1,705 $302,000
Q4 2021

Jan 28, 2022

SELL
$155.93 - $173.01 $20,426 - $22,664
-131 Reduced 7.34%
1,654 $283,000
Q3 2021

Oct 14, 2021

BUY
$161.5 - $179.47 $183,787 - $204,236
1,138 Added 175.89%
1,785 $288,000
Q2 2021

Aug 10, 2021

SELL
$159.48 - $171.07 $14,512 - $15,567
-91 Reduced 12.33%
647 $107,000
Q1 2021

May 10, 2021

SELL
$153.07 - $170.48 $13,010 - $14,490
-85 Reduced 10.33%
738 $121,000
Q4 2020

Feb 10, 2021

BUY
$137.11 - $157.38 $137 - $157
1 Added 0.12%
823 $130,000
Q1 2020

May 04, 2020

SELL
$111.14 - $153.99 $13,336 - $18,478
-120 Reduced 12.74%
822 $108,000
Q4 2019

Jan 31, 2020

SELL
$127.5 - $146.44 $1,020 - $1,171
-8 Reduced 0.84%
942 $137,000
Q3 2019

Nov 08, 2019

BUY
$126.95 - $142.14 $23,358 - $26,153
184 Added 24.02%
950 $123,000
Q2 2019

Aug 06, 2019

SELL
$131.15 - $144.24 $26,361 - $28,992
-201 Reduced 20.79%
766 $107,000
Q1 2019

May 14, 2019

BUY
$125.72 - $139.79 $55,442 - $61,647
441 Added 83.84%
967 $135,000
Q3 2018

Nov 19, 2018

SELL
$121.58 - $142.88 $10,699 - $12,573
-88 Reduced 14.33%
526 $73,000
Q2 2018

Aug 08, 2018

SELL
$119.4 - $131.76 $22,805 - $25,166
-191 Reduced 23.73%
614 $75,000
Q1 2018

Apr 30, 2018

BUY
$125.1 - $148.14 $100,705 - $119,252
805 New
805 $103,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $419B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Financial Enhancement Group LLC Portfolio

Follow Financial Enhancement Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Enhancement Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Enhancement Group LLC with notifications on news.